Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126156031 | 12615603 | 1 | I | 20160727 | 20160802 | 20160802 | EXP | PK-009507513-1607PAK012950 | MERCK | 0.00 | Y | 0.00000 | 20160802 | OT | PK | PK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126156031 | 12615603 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 20903 | TABLET | ||||||||||
| 126156031 | 12615603 | 2 | SS | PEGINTERFERON ALFA-2B | PEGINTERFERON ALFA-2B | 1 | 0 | POWDER FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126156031 | 12615603 | 1 | Hepatitis C virus test positive |
| 126156031 | 12615603 | 2 | Hepatitis C virus test positive |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126156031 | 12615603 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126156031 | 12615603 | Hepatitis C |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |